These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 2903264)
1. Inactivation of dynorphin-(1-8) in isolated preparations by three peptidases. Numata H; Hiranuma T; Oka T Jpn J Pharmacol; 1988 Aug; 47(4):417-23. PubMed ID: 2903264 [TBL] [Abstract][Full Text] [Related]
2. Protection against dynorphin-(1-8) hydrolysis in membrane preparations by the combination of amastatin, captopril and phosphoramidon. Hiranuma T; Kitamura K; Taniguchi T; Kanai M; Arai Y; Iwao K; Oka T J Pharmacol Exp Ther; 1998 Aug; 286(2):863-9. PubMed ID: 9694943 [TBL] [Abstract][Full Text] [Related]
3. Estimation of relative importance of three enzymes in the inactivation of [Met5]-enkephalin and [Met5]-enkephalin-Arg6 in three isolated preparations by employing the inhibitor specific for each enzyme. Kuno Y; Oka T Jpn J Pharmacol; 1987 Jul; 44(3):241-7. PubMed ID: 2821306 [TBL] [Abstract][Full Text] [Related]
4. The enhancing effects of amastatin, phosphoramidon and captopril on the potency of [Met5]-enkephalin in rat vas deferens. Cui SY; Kajiwara M; Ishii K; Aoki K; Sakamoto J; Matsumiya T; Oka T Jpn J Pharmacol; 1986 Sep; 42(1):43-9. PubMed ID: 3540390 [TBL] [Abstract][Full Text] [Related]
5. [Enkephalin-inactivating enzymes]. Oka T; Hiranuma T; Liu XF; Ohgiya N; Iwao K; Matsumiya T Nihon Yakurigaku Zasshi; 1993 Apr; 101(4):197-207. PubMed ID: 8390390 [TBL] [Abstract][Full Text] [Related]
6. The choice of opioid receptor subtype in isolated preparations by dynorphins. Oka T; Aoki K; Kajiwara M Life Sci; 1983; 33 Suppl 1():311-4. PubMed ID: 6141492 [TBL] [Abstract][Full Text] [Related]
7. The relative potency of enkephalins and beta-endorphin in guinea-pig ileum, mouse vas deferens and rat vas deferens after the administration of peptidase inhibitors. Kuno Y; Aoki K; Kajiwara M; Ishii K; Oka T Jpn J Pharmacol; 1986 Jul; 41(3):273-81. PubMed ID: 3761746 [TBL] [Abstract][Full Text] [Related]
8. The inactivation of [Met5]-enkephalin by bestatin-sensitive aminopeptidase, captopril-sensitive peptidyl dipeptidase A and thiorphan-sensitive endopeptidase-24.11 in mouse vas deferens. Aoki K; Kajiwara M; Oka T Jpn J Pharmacol; 1986 Feb; 40(2):297-302. PubMed ID: 3009948 [TBL] [Abstract][Full Text] [Related]
9. Inactivation of [Leu5]-enkephalin in three isolated preparations: relative importance of aminopeptidase, endopeptidase-24.11 and peptidyl dipeptidase A. Oka T; Aoki K; Kajiwara M; Ishii K; Kuno Y; Hiranuma T; Matsumiya T NIDA Res Monogr; 1986; 75():259-62. PubMed ID: 2828976 [TBL] [Abstract][Full Text] [Related]
11. Evidence that dynorphin-(1-13) acts as an agonist on opioid kappa-receptors. Oka T; Negishi K; Suda M; Sawa A; Fujino M; Wakimasu M Eur J Pharmacol; 1982 Jan; 77(2-3):137-41. PubMed ID: 6277659 [TBL] [Abstract][Full Text] [Related]
12. Effects of three peptidase inhibitors, amastatin, captopril and phosphoramidon, on the hydrolysis of [Met5]-enkephalin-Arg6-Phe7 and other opioid peptides. Hiranuma T; Kitamura K; Taniguchi T; Kobayashi T; Tamaki R; Kanai M; Akahori K; Iwao K; Oka T Naunyn Schmiedebergs Arch Pharmacol; 1998 Mar; 357(3):276-82. PubMed ID: 9550299 [TBL] [Abstract][Full Text] [Related]
13. Peptidases prevent mu-opioid receptor internalization in dorsal horn neurons by endogenously released opioids. Song B; Marvizón JC J Neurosci; 2003 Mar; 23(5):1847-58. PubMed ID: 12629189 [TBL] [Abstract][Full Text] [Related]
14. Characterization of somatostatin receptors in guinea-pig isolated ileum, vas deferens and right atrium. Feniuk W; Dimech J; Humphrey PP Br J Pharmacol; 1993 Nov; 110(3):1156-64. PubMed ID: 7905341 [TBL] [Abstract][Full Text] [Related]
15. Great increase in antinociceptive potency of [Leu5]enkephalin after peptidase inhibition. Akahori K; Kosaka K; Jin XL; Arai Y; Yoshikawa M; Kobayashi H; Oka T J Pharmacol Sci; 2008 Feb; 106(2):295-300. PubMed ID: 18296865 [TBL] [Abstract][Full Text] [Related]
16. Irreversible blockade of the kappa-receptor by a newly synthesized dynorphin derivative containing a 3-nitro-2-pyridinesulfenyl group. Koike K; Takayanagi I; Hirakura Y; Matsueda R Arch Int Pharmacodyn Ther; 1991; 313():33-46. PubMed ID: 1687773 [TBL] [Abstract][Full Text] [Related]
17. Effects of peptidase inhibitors on the [Met5]-enkephalin hydrolysis in ileal and striatal preparations of guinea-pig: almost complete protection of degradation by the combination of amastatin, captopril and thiorphan. Hiranuma T; Oka T Jpn J Pharmacol; 1986 Aug; 41(4):437-46. PubMed ID: 3534399 [TBL] [Abstract][Full Text] [Related]
18. Almost complete protection from [Met5]-enkephalin-Arg6-Gly7-Leu8 (Met-enk-RGL) hydrolysis in membrane preparations by the combination of amastatin, captopril and phosphoramidon. Hiranuma T; Iwao K; Kitamura K; Matsumiya T; Oka T J Pharmacol Exp Ther; 1997 May; 281(2):769-74. PubMed ID: 9152384 [TBL] [Abstract][Full Text] [Related]
19. The role of bestatin-sensitive aminopeptidase, angiotensin converting enzyme and thiorphan-sensitive "enkephalinase" in the potency of enkephalins in the guinea-pig ileum. Aoki K; Kajiwara M; Oka T Jpn J Pharmacol; 1984 Sep; 36(1):59-65. PubMed ID: 6094902 [TBL] [Abstract][Full Text] [Related]
20. Dynorphin A(1-8): stability and implications for in vitro opioid activity. Bell KM; Traynor JR Can J Physiol Pharmacol; 1998 Mar; 76(3):325-33. PubMed ID: 9673796 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]